Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

WELLBUTRIN for Smoking cessation therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where WELLBUTRIN was used for Smoking cessation therapy.

Most Reported Side Effects for WELLBUTRIN

Side Effect Reports % Deaths Hosp.
Drug hypersensitivity 45 12.3% 0 0
Drug ineffective 40 10.9% 0 6
Depression 25 6.8% 0 5
Nausea 24 6.6% 0 4
Convulsion 23 6.3% 2 10
Dizziness 19 5.2% 0 3
Malaise 18 4.9% 0 6
Suicidal ideation 18 4.9% 0 7
Feeling abnormal 17 4.6% 0 3
Anxiety 15 4.1% 0 0
Balance disorder 14 3.8% 0 1
Rash 13 3.6% 0 5
Agitation 12 3.3% 2 5
Headache 11 3.0% 0 2
Insomnia 11 3.0% 1 2

Other Indications for WELLBUTRIN

Product used for unknown indication (121) Depression (104) Anxiety (14) Ex-tobacco user (7) Major depression (6)

Other Drugs Used for Smoking cessation therapy

NICOTINE (16,741) VARENICLINE (9,055) CHANTIX (889) BUPROPION (702) CHAMPIX (116) NICOTROL (51) UNSPECIFIED INGREDIENT (17) NICORETTE (15) ZYBAN (14) NICODERM CQ (12)

Related Pages

WELLBUTRIN Full Profile All Smoking cessation therapy Drugs WELLBUTRIN Demographics WELLBUTRIN Timeline